Paloma Partners’s Mead Johnson Nutrition Company MJN Stock Holding History

Paloma Partners’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-26,000	Closed	-$1.84M	–	2412
2016 Q4	$1.84M	Buy	26,000 +10,000	+63%	+$745K	0.02%	731
2016 Q3	$1.26M	Hold	16,000	–	–	0.02%	838
2016 Q2	$1.45M	Buy	+16,000	New	+$1.35M	0.02%	916

Other funds holding MJN

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

FNBOO

First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return

LFAS

Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

WEC

Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Paloma Partners's MJN Position: Q2 2017 in Review

Paloma Partners sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 79,765 shares — an estimated $7.11M sold.

Paloma Partners first reported a position in MJN in Q2 2013 and held it in 13 quarters. The position peaked at $7.11M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

Paloma Partners reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
Paloma Partners sold 79,765 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $7.11M.
Paloma Partners first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 13 quarters.
Paloma Partners's Mead Johnson Nutrition Company position peaked at $7.11M in Q1 2017.
7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Paloma Partners's 13F filing for Q2 2017, filed 14 Aug 2017.